Michael W. Schwartz MD

UW Metabolism, Endocrinology and Nutrition
Professor and Director, UW Medicine Diabetes Institute

Email: mschwart@uw.edu | Phone: 206.897.5288

Through a multi-institutional collaborative effort we have recently created the Diabetes-Stem Cell Program (DSCP) whose overarching goal is to unite expertise in stem cell biology with that in developmental biology of pancreatic beta cells, basic and clinical aspects of diabetes, implantation biology, and immunology in a joint scientific endeavor. Key objectives of the DSCP include not only the creation and commercialization of a new, cell-based method for diabetes treatment, but also the development of strategies to eliminate the risk of tumor formation in cell implants, and to optimize methods for cell differentiation and metabolic analysis.